By Mill Chart
Last update: Apr 8, 2024
Get insights into the top gainers and losers of Monday's after-hours session.
Ticker | Change | Comment |
---|---|---|
BENF | 28.92% | BENEFICIENT - CLASS A (NASDAQ:BENF) rose 28.92% to $0.11 during Monday's after hours session. After a notable 61.17% gain earlier today, NASDAQ:BENF maintains its positive momentum during the after-hours session. |
KITT | 21.84% | Positive market activity for NAUTICUS ROBOTICS INC (NASDAQ:KITT) after regular trading hours, with a 21.84% increase to $0.32 in the after-hours session on Monday. NASDAQ:KITT released their earnings today. In the last 3 months the share price dropped with 50.57%. |
KA | 16.67% | Positive after-hours movement for KINETA INC (NASDAQ:KA) as its shares recorded a 16.67% increase, reaching $0.63 during Monday's after-hours session. In the last month the share price dropped with 22.3%. |
WINT | 14.63% | WINDTREE THERAPEUTICS INC's (NASDAQ:WINT) shares rose 14.63% to $0.47 during Monday's after hours session. In the last 3 months the stock lost 28.35%. |
AEHL | 9.25% | ANTELOPE ENTERPRISE HOLDINGS (NASDAQ:AEHL) rose 9.25% to $1.66 during Monday's after hours session. In the last 6 months the share price dropped with 42.64%. |
GNLN | 7.84% | GREENLANE HOLDINGS INC - A (NASDAQ:GNLN) showcases remarkable after-hours performance, with a 7.84% rise to $0.55 during Monday's after-hours trading. In the last 6 months the stock lost 21.72%. |
ASST | 7.69% | ASSET ENTITIES INC-B (NASDAQ:ASST) showcases remarkable after-hours performance, with a 7.69% rise to $0.42 during Monday's after-hours trading. In the last month the stock lost 32.76%. |
ALLR | 6.93% | After the closing bell, ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) demonstrated strong momentum in the after-hours session, with a 6.93% rise to $0.23. In the last month the stock lost 46.37%. |
BCLI | 6.63% | BRAINSTORM CELL THERAPEUTICS (NASDAQ:BCLI) rose 6.63% to $0.78 during Monday's after hours session. Today's gain of 12.14% continues in today's after hours session with 6.63%. |
CHSN | 6.56% | Notable gains for CHANSON INTERNATIONAL HOLD-A (NASDAQ:CHSN) in the after-hours session, with a 6.56% rise to $1.95 during Monday. The stock is trading 39.69% higher than 3 months ago. |
To see the full list of after hours gainers you can use our after hours gainers page.
Ticker | Change | Comment |
---|---|---|
VINC | -44.77% | Following a -13.87% loss in the regular session, NASDAQ:VINC exhibits further decline during today's after-hours session. Following a -13.87% loss in the regular session, NASDAQ:VINC sees no respite as the after-hours session continues the downward trajectory. |
WTO | -17.2% | UTIME LTD's (NASDAQ:WTO) stock price saw a decrease of 17.2% to $0.25 during Monday's after-hours session. Prices are quite volatile now: this is a reversal from 62.16% gain. |
SMFL | -8.83% | SMART FOR LIFE INC's (NASDAQ:SMFL) shares experienced a 8.83% decrease to $0.63 in the after-hours session. Price movements remain volatile as NASDAQ:SMFL gives back 38.88% of its earlier gains in the after-hours session. |
MAXN | -8.8% | MAXEON SOLAR TECHNOLOGIE's (NASDAQ:MAXN) stock price decreased by 8.8% to $2.49. In the last month the stock lost 26.02%. |
TPET | -8.54% | Price volatility persists as NYSEARCA:TPET closed the regular session with a %ABSPERF% loss, and the downward trend continues in the after-hours session. The stock is trading 40.4% higher than a month ago. |
BSGM | -8.47% | BIOSIG TECHNOLOGIES INC's (NASDAQ:BSGM) stock price is showing a decline of 8.47% to a price of $1.14 during the after-hours session. After registering a 91.56% gain earlier today, NASDAQ:BSGM is experiencing a 8.47% decline in today's after-hours session. |
STRC | -6.91% | The after-hours session reflects NASDAQ:STRC's ongoing correction after experiencing a 27.46% loss in the regular trading hours. Price volatility intensifies as NASDAQ:STRC retraces its 27.46% gain during the after-hours session. A press release (Palladyne AI Ticker Symbol now PDYN) was released yesterday. |
OPGN | -6.14% | Price volatility persists as NASDAQ:OPGN closed the regular session with a %ABSPERF% loss, and the downward trend continues in the after-hours session. In the last month the share price increased with 47.17%. |
RELI | -5.53% | Following a -12.63% loss in the regular session, NASDAQ:RELI exhibits further decline during today's after-hours session. The after-hours session reflects NASDAQ:RELI's ongoing correction after a -12.63% loss in the regular trading hours. |
GLMD | -5.28% | GALMED PHARMACEUTICALS LTD's (NASDAQ:GLMD) stock price saw a decrease of 5.28% to $0.38 during Monday's after-hours session. After registering a 16.72% gain earlier today, NASDAQ:GLMD is experiencing a 5.28% decline in today's after-hours session. |
To see the full list of after hours losers you can use our after hours losers page.
BRAINSTORM CELL THERAPEUTICS
NASDAQ:BCLI (4/29/2024, 5:49:33 PM)
0.54
+0.01 (+1.03%)
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI, "the Company"), a leading developer of cellular therapies for neurodegenerative diseases,...
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the...
Get insights into the top gainers and losers of Tuesday's after-hours session.
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...
BCLI stock results show that Brainstorm Cell beat analyst estimates for earnings per share the fourth quarter of 2023.
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
BrainStorm Cell Therapeutics (BCLI) said it has submitted a Special Protocol Assessment request to the FDA for a Phase 3b study of its cell therapy NurOwn in the treatment of ALS.
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...